MEI Pharma, Inc. (MEIP)

[ryanbmw]

Yes the update will be exciting, for those who listened to the presentation the other day, they said that the reason the results were not as good as intended were because of patients intolerance for the drug. Because of either natural intolerance which forced them to stop taking it, and those whose condition was at the terminal stage where they passed away. I'm not for sure on the numbers but I thought he said like 25-30% of the data was based on those intolerance patients as well. So I'd like to see the data just from the patients who's were on the drug the whole study. IMHO very good news will come when they take that into account and/or adjust and do a reassessment.